WallStreetZenWallStreetZen

NYSE: DGX
Quest Diagnostics Inc Stock

$142.81-2.66 (-1.83%)
Updated Feb 3, 2023
DGX Price
$142.81
Fair Value Price
N/A
Market Cap
$16.26B
52 Week Low
$120.40
52 Week High
$158.34
P/E
13.74x
P/B
2.61x
P/S
1.38x
PEG
N/A
Dividend Yield
1.85%
Revenue
$10.29B
Earnings
$1.24B
Gross Margin
36%
Operating Margin
17.1%
Profit Margin
12%
Debt to Equity
1.12
Operating Cash Flow
$2B
Beta
0.65
Next Earnings
N/A
Ex-Dividend
Apr 6, 2023
Next Dividend
Apr 24, 2023

DGX Overview

Quest Diagnostics Incorporated operates clinical laboratories in the U.S, Puerto Rico, Mexico, and Brazil. The company also maintains collaborative agreements with hospitals and clinics around the world. The company offers diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, and COVID-19, as well as employment and court-ordered drug testing. Quest Diagnostics was founded in 1967 and is headquartered in Secaucus, NJ.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DGX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DGX is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DGX is good value based on its earnings relative to its share price (13.74x), compared to the US market average (15.09x)
P/E vs Market Valuation
DGX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more DGX due diligence checks available for Premium users.

Be the first to know about important DGX news, forecast changes, insider trades & much more!

DGX News

Valuation

DGX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
13.74x
Industry
37.84x
Market
15.09x
DGX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DGX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

DGX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.61x
Industry
4.54x
DGX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DGX's financial health

Profit margin

Revenue
$2.5B
Net Income
$256.0M
Profit Margin
10.3%
DGX's Earnings (EBIT) of $1.76B... subscribe to Premium to read more.
Interest Coverage Financials
DGX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$13.2B
Liabilities
$7.0B
Debt to equity
1.12
DGX's short-term assets ($2.33B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DGX's long-term liabilities ($5.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DGX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DGX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$502.0M
Investing
-$118.0M
Financing
-$474.0M
DGX's operating cash flow ($1.87B)... subscribe to Premium to read more.
Debt Coverage Financials

DGX vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
DGX$16.26B-1.83%13.74x2.61x
PHG$15.41B-2.85%4.25x0.94x
PKI$17.91B-1.82%28.64x2.53x
CRL$12.74B-3.68%29.04x4.85x
ICLR$19.91B-0.53%42.07x2.42x

Quest Diagnostics Stock FAQ

What is Quest Diagnostics's quote symbol?

NYSE: DGX) Quest Diagnostics trades on the NYSE under the ticker symbol DGX. Quest Diagnostics stock quotes can also be displayed as NYSE: DGX.

If you're new to stock investing, here's how to buy Quest Diagnostics stock.

What is the 52 week high and low for Quest Diagnostics (NYSE: DGX)?

(NYSE: DGX) Quest Diagnostics's 52-week high was $158.34, and its 52-week low was $120.40. It is currently -9.81% from its 52-week high and 18.61% from its 52-week low.

How much is Quest Diagnostics stock worth today?

(NYSE: DGX) Quest Diagnostics currently has 113,887,466 outstanding shares. With Quest Diagnostics stock trading at $142.81 per share, the total value of Quest Diagnostics stock (market capitalization) is $16.26B.

Quest Diagnostics stock was originally listed at a price of $4.22 in Dec 31, 1997. If you had invested in Quest Diagnostics stock at $4.22, your return over the last 25 years would have been 3,284.12%, for an annualized return of 15.13% (not including any dividends or dividend reinvestments).

How much is Quest Diagnostics's stock price per share?

(NYSE: DGX) Quest Diagnostics stock price per share is $142.81 today (as of Feb 3, 2023).

What is Quest Diagnostics's Market Cap?

(NYSE: DGX) Quest Diagnostics's market cap is $16.26B, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quest Diagnostics's market cap is calculated by multiplying DGX's current stock price of $142.81 by DGX's total outstanding shares of 113,887,466.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.